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RESEARCH ARTICLE
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NADPH oxidase 5 (NOX5) generated reactive oxygen species (ROS) have been
implicated in signaling cascades that regulate cancer cell proliferation. To evaluate and
validate NOX5 expression in human tumors, we screened a broad range of tissue
microarrays (TMAs), and report substantial overexpression of NOX5 in malignant
melanoma and cancers of the prostate, breast, and ovary. In human UACC-257
melanoma cells that possesses high levels of functional endogenous NOX5, over-
expression of NOX5 resulted in enhanced cell growth, increased numbers of BrdU
positive cells, and increased γ-H2AX levels. Additionally, NOX5-overexpressing (stable
and inducible) UACC-257 cells demonstrated increased normoxic HIF-1α expression
anddecreased p27Kip1 expression. Similarly, increased normoxicHIF-1α expression and
decreased p27Kip1 expression were observed in stable NOX5-overexpressing clones of
KARPAS 299 human lymphoma cells and in the human prostate cancer cell line, PC-3.
Conversely, knockdownof endogenousNOX5 inUACC-257 cells resulted in decreased
cell growth, decreased HIF-1α expression, and increased p27Kip1 expression. Likewise,
in an additional human melanoma cell line, WM852, and in PC-3 cells, transient
knockdown of endogenous NOX5 resulted in increased p27Kip1 and decreased HIF-1α
expression. Knockdown of endogenousNOX5 inUACC-257 cells resulted in decreased
Akt andGSK3β phosphorylation, signaling pathways known tomodulate p27Kip1 levels.
In summary, our findings suggest thatNOX5expression inhumanUACC-257melanoma
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in
any medium, provided the original work is properly cited and is not used for commercial purposes.
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Abbreviations: 7 AAD, 7-aminoactinomycin D; Akt, protein kinase B; ALK, anaplastic lymphoma kinase; AMPK, 5′ adenosine monophosphate-activated protein kinase; BAPTA-AM, 1,2-Bis(2-
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester); BrdU, 5-bromo-2′-deoxyuridine; Ca2+, calcium ions; CDK, cyclin-dependent kinases; DCF, 2′,7′-dichlorofluor-
escein; DPI, diphenyleneiodonium; DTT, dithiothreitol; DNase, deoxyribonuclease; DUOX, dual oxidase; FAD, flavin adenine dinucleotide; Fe2+, ferrous ion; FOXO, forkhead box protein O;
G418, geneticin; GSK3, glycogen synthase kinase 3; H2-DCFDA, 2′,7′-dichlorodihydrofluorescein diacetate; H2O2, hydrogen peroxide; H2AX, histone H2AX; HA-tag, hemagglutinin tag; HIF-
1α, hypoxia-inducible factor 1-alpha; HRP, horseradish peroxidase; KRPG, krebs-ringer phosphate glucose buffer; MAPK, mitogen activated protein kinase; NAC, N-Acetyl-L-Cysteine;
NADP+, nicotinamide adenine dinucleotide phosphate oxidized; NADPH, nicotinamide adenine dinucleotide phosphate reduced; NOX, NADPH oxidase; p27Kip1, cyclin-dependent kinase
inhibitor 1B; PBS, phosphate-buffered saline; PEG, polyethylene glycol; PIM, proto-oncogene serine/threonine-protein kinase; PMA, phorbol-12-myristate-13-acetate; RT-PCR, reverse
transcription—polymerase chain reaction; ROS, reactive oxygen species; SDS, sodium dodecyl sulfate; SOD, superoxide dismutase; sh, short hairpin; siRNA, small interfering RNA; TBST, tris-
buffered saline with 0.1% Tween 20; TMA, tissue microarray.
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cells could contribute to cell proliferation due, in part, to the generation of high local
concentrations of extracellular ROS thatmodulatemultiple pathways that regulateHIF-
1α and networks that signal through Akt/GSK3β/p27Kip1.
K E YWORD S
Akt/GSK3 signaling, cell growth, DNA damage, NADPH oxidase, reactive oxygen species
(ROS), tumor microarray (TMA)
1 | INTRODUCTION
A growing body of evidence supports a dual role for reactive oxygen
species (ROS) as signaling molecules.1–3 Controlled ROS production
regulates normal cellular physiological functions4; but in excess, ROS are
detrimental to thecell resulting in cell differentiationand/or cell death.1,5,6
Much recent research has focused on how low levels of intracellular ROS
(10-100 nM) regulate tumor growth by facilitating mutagenesis, tumor
initiation, and tumor promotion.6,7 Members of the NAPDH oxidase
(NOX) family play a major role in generating ROS in a broad range of cell
types.1,8–10 This 7-membered family is comprised of NOXes 1-5 and
DUOX 1 and 2 proteins that function to generate ROS by oxidizing
NADPH to NADP+.11–13 The vital roles that NOX-mediated ROS play in
host defense, metabolism, and the control of vascular tone are well
documented.14–16 More recently, several studies have reported upregu-
lated RNA and protein expression levels of the NOX family of proteins in
human tumors, as well as a link between expression levels and cancer cell
proliferation.6,9,10,17,18 NOX1 expression has been linked to colon cancer;
a role for NOX1 in the etiology of gastric and prostate cancers has also
been suggested.9,17,19,20 Increased NOX4 expression has been found
predominantly in tumors of the brain, ovary, and kidney, as well as in
melanoma.9,17,21 NOX5 has been measured primarily in the context of
prostate, breast, and esophageal cancer22–25; and DUOX1 and DUOX2
have been found in thyroid, lung, and pancreatic cancers.9,17,26
Of the tumor-associated NOXes reported thus far, the role of
NADPH oxidase 5 (NOX5) is the least well understood; largely, this is
because of a paucity of animal-based studies due to the lack of NOX5
expression in rodents.27–29 Structurally like the other NOXes, NOX5 is
anchored to the plasma membrane through its six transmembrane
helices that can bind two heme cofactors and allow for NADPH
oxidation through a C-terminal FAD/NADPH binding domain.17,30–35
However, although regulated by calcium, NOX5 has no known
interaction partner essential for its activity.29,35,36 Several studies
report correlations betweenNOX5 expression and tumorigenesis23,37;
yet, limited evidence exists detailing the signaling role of NOX5 in
tumor biology. Such studies include, but are not limited to, explorations
of the role of NOX5 in hairy cell leukemia,38 ALK-positive anaplastic
large-cell lymphoma,39 prostate cancer,22,24,40 and esophageal ade-
nocarcinoma.25,41,42 Recently, our laboratory reported the characteri-
zation of NOX5 expression in human tumors and tumor cell lines using
a new NOX5 monoclonal antibody.22 Preliminary human tumor
microarray (TMA) analysis revealed high levels of NOX5 expression,
with a frequency of intermediate to strong expression in 57-70% of
several human tumors, including prostate cancer and melanoma.22
Detection of elevated expression levels of NOX5 in a variety of human
malignancies led us to further explore the functional significance of
NOX5 in the context of tumorigenesis.
In this study, we performed a more detailed evaluation of NOX5
expression across several tumor microarrays to assess the frequency of
NOX5 expression in a larger sample of human malignancies. Here, we
validate our initial findings and report substantial overexpression of
NOX5, compared to histologically normal tissues, in several human
cancers including thoseofprostateandbreastand inmalignantmelanoma.
We also report NOX5 expression across a panel of humanmelanoma cell
lines, with theUACC-257 line having the highest endogenous expression.
Functional NOX5-derived ROS production in UACC-257 cells regulates
normoxic HIF-1α and p27Kip1 expression. Additionally, NOX5 over-
expression modulates γH2AX levels and the growth of the UACC-257
melanoma line. These results were confirmed in additional human tumor
cell models that possess functional NOX5 activity.
2 | MATERIALS AND METHODS
2.1 | Reagents and antibodies
Anti-β-Actin antibody (#A3853), N-Acetyl-L-Cysteine (NAC; #A7250),
Doxycycline hydrochloride (#D3447), Ampicillin sodium salt (#A0166),
Diphenyleneiodonium chloride (DPI; #D-2926), Catalase (#C1345), PEG-
Catalase (#C4963), and PEG-SOD (#S9549) were purchased from Sigma-
Aldrich (St. Louis, MO); Geneticin G418 (#G5005) was from Teknova
(Hollister, CA); Ionomycin (#407952), Phorbol-12-myristate-13-acetate
(PMA; #524400), and BAPTA-AM (#196419) were from EMDChemicals
(Billerica, MA); Akt (#4691), p-Akt (Ser473) (#4058), GSK3β (#9315), p-
GSK3β (Ser9) (#9336), Lamin A/C (#2032), SKP2 (#4313) antibodieswere
from Cell Signaling Technology (Danvers; MA); HIF-1α (#610959) and
p27Kip1 (#610241) antibodies were from BD Biosciences (San Jose, CA);
p27Kip1 phospho (pT157) (#T3757) and p27Kip1 phospho (pS10)
(#ab62364) antibodies were purchased from Abcam (Cambridge, MA);
and Anti-HA antibody (#11867423001) was purchased from Roche-
Applied Science (Indianapolis, IN). Restriction enzymes BamH1
(#R0136S), BglII (#R0144S), ECORV (#R0195S) and T4 DNA ligase
(#M0202S) were purchased from New England Biolabs (Ipswich, MA).
Opti-MEM® reduced serum medium (#11058-021), MAX Efficiency®
DH5α™ competent Cells (#18258012), Puromycin dihydrochloride
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(#A1113803), 2′,7′-Dichlorodihydrofluorescin diacetate (H2-DCFDA,
#D399) were obtained from Thermo Fisher Scientific (Rockford, IL). LB
plates containing ampicillin (#BPL-2200) were purchased from KD
Medical (Columbia, MD). Human anti-NOX5 antibody was previously
developed by Creative Biolabs (Port Jefferson Station, NY) and
characterized by our laboratory. NOX5β (accession number AF325189)
subcloned into a modified pcDNA3 containing an N-terminal HA epitope
was a kind gift from Dr. David J. R. Fulton (Medical College of Georgia).
2.2 | Cell culture and transfection
The human melanoma cell lines LOX IMVI, M14, MALME-3M,
SK-MEL-2, SK-MEL-5, SK-MEL-28, UACC-62, and UACC-257 were
obtained from the Developmental Therapeutics Program, Division of
Cancer Treatment and Diagnosis of the National Cancer Institute,
Frederick, MD and were cultured in RPMI-1640 medium
(SH30255.01; HyClone) supplemented with 10% FBS (#100-106;
Gemini Bio Products). The melanoma cell lines Lu1205 (#1205 Lu-
01-0001), WM115 (#WM115-01-0001), WM852 (#WM852-01-
0001), and WM1158 (#WM1158-01-0001) were obtained from
Rockland Immunochemicals Inc., and maintained in 2% melanoma
media (4:1 mixture of MCDB153 and L15, supplemented with 2mM
Ca2+, 2% FBS, and 5 μg/mL insulin). The melanoma cell lines
SK-MEL-3 (#HTB-69), G-361 (#CRL-1424), and HT-144 (#HTB-63)
were obtained from ATCC and maintained in McCoy's 5a Medium
Modified (#30-2007, ATCC) with 15% FBS for SK-MEL-3 and G-361
cells and 10% FBS for HT-144 cells. A375 (#CRL-1619), A2058
(#CRL-11147), SH-4 (# CRL-7724), and Hs895-T (#CRL-7637)
melanoma cell lines from ATCC were maintained in Dulbecco's
Modified Eagle's Medium (#30-2002, ATCC) with 10% FBS. Hs895-
Sk (#CRL-7636) cell line from ATCC was maintained in Dulbecco's
modified Eagle's medium (4mM L-glutamine adjusted to contain
1.5 g/L sodium bicarbonate, 4.5 g/L glucose) containing 10% FBS.
RPMI-7951 (#HTB-66) and SK-MEL-24 (#HTB-71) melanoma cell
lines from ATCC were maintained in Eagle's Minimum Essential
Medium (#30-2003, ATCC) containing 10% and 15% FBS, respec-
tively. PC-3 human prostate cancer cells (#CRL-1435) were obtained
from ATCC and maintained in F-12 K medium (#30-2004, ATCC)
supplemented with 10% FBS. Human KARPAS 299 lymphoma cell
line (#06072604) was obtained from Sigma and cultured in RPMI-
1640 medium supplemented with 2 mM glutamine and 10% FBS. All
cell lines were maintained at 37°C in 5% CO2 and 95% air and
humidified atmosphere. The identity of the cell lines was confirmed
by the Genetic Resources Core Facility of Johns Hopkins University
(Baltimore, MD).
Transfection was carried out using Lipofectamine® 2000
(#11668019, Invitrogen/Thermo Fisher Scientific) according to the
manufacturer's protocol. To generate cells that stably overexpress
NOX5 (UACC-257, PC-3 and KARPAS 299), cells were transfected
with a pcDNA3-NOX5β plasmid (kind gift from Dr. Fulton) or empty
vector using Lipofectamine® 2000. Resistant clones were selected
with 700 µg/mL of G418, and then single clones were selected and
maintained under G418 selection. For generating the NOX5-
inducible expression system, the Tet-On 3G inducible expression
system (#631167, Clontech) that contains the regulator plasmid
pEF1α-Tet3G and the response plasmid pTRE3G was used. To clone
NOX5β into the pTRE3G vector, the pcDNA3-NOX5β plasmid was
digested with BamH1 and ECORV, and the pTRE3G vector was
digested with BglII and ECORV. Subsequent to purification of the
fragments and ligation using T4 ligase and transformation in DH5α
competent cells, ampicillin-resistant single bacterial colonies were
isolated and the plasmid DNA was isolated (QIAprep® spin miniprep
kit, #27104, Qiagen, Germantown, MD). Purified plasmid DNA was
confirmed by restriction enzyme digestion and sequencing as the
pTRE3G-NOX5β expression plasmid.
To generate UACC-257 cells that express inducible NOX5,
parental UACC-257 cells were transfected with the pEF1α-Tet3G
vector and clones that were resistant to G418 and constitutively
express the Tet-On 3G transactivator were selected. Positive clones
were next transfected with the pTRE3G-NOX5β expression vector
along with a linear selection marker (Purr). After a second round of
selection, double-stable clones (G418 and puromycin resistant) that
express high levels of NOX5 in response to doxycycline were
established.
For gene silencing experiments, log-phase cells (UACC-257, PC-3,
WM852) were trypsinized and transfected with 5 nM of either control
or three different NOX5 Stealth Select RNAi's (Stealth Select RNAi™
siRNA #HSS128401, #HSS128402, #HSS128403, Invitrogen) using the
Lipofectamine™ RNAiMAX transfection reagent (#13778-075, Invitro-
gen). After 72 h of transfection, silencing efficiency was analyzed by
measuring NOX5 at the RNA level by TaqMan real-time PCR and/or
protein level by immunoblotting. Stealth scrambled siRNA transfections
(Stealth RNAi Negative Control Duplexes #12935-100, Invitrogen)
were used as controls. Effect of transient NOX5 knockdown on the
growth ofWM852 cells was evaluated 6 days after log-phase cells were
trypsinizedandtransfectedwith5nMofeither scrambledcontrol siRNA
or two different NOX5 Stealth Select RNAi's (Stealth Select RNAi™
siRNA #HSS128401 and #HSS128402, Invitrogen) using the Lipofect-
amine™ RNAiMAX transfection reagent (#13778-075, Invitrogen). To
evaluate the effect of HIF-1α, UACC-257 cells that stably overexpress
NOX5 (Clone 3) and WM852 cells were transiently transfected with
either control scrambled siRNA (Stealth RNAi Negative Control
Duplexes #12935-100, Invitrogen) or with two different HIF-1α
Silencer® Select RNAi's (#s6539 and #s6541, Invitrogen) using the
Lipofectamine™ RNAiMAX transfection reagent (#13778-075, Invitro-
gen) and evaluated 6 days after transfection.
To generate UACC-257 cells that are stably knocked down for
NOX5 expression, three different NOX5shRNA plasmids that target
different sequences on NOX5, and the control shRNA plasmid, were
purchased from Qiagen (#336313, KH17569N). Parental UACC-257
cells were transfected with the four plasmids individually and selected
with G418 at a concentration of 700 μg/ml. G418-resistant clones
were screened and examined for NOX5 expression at both the mRNA
and protein levels; validated vector shRNA clones and NOX5shRNA
clones derived from three different NOX5shRNA plasmids were
maintained under G418 selection.
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2.3 | Immunohistochemical determination of NOX5
expression in human tumor tissue microarrays
Unstained slides from formalin-fixed, paraffin-embedded tissue micro-
array (TMA) blocks were purchased from US Biomax. These included:
Colon disease tissue arrays #BC05002 and # CO809a; Breast invasive
ductal carcinoma tissue array #BC08118; Breast cancer tissue array
#BR1505b; Lung cancer tissue array #LC2085b; Mid-advanced stage
ovary cancer tissue array #OV8010; Prostate cancer tissue array
#PR2085b; and Tissue array of gastritis with intestinal metaplasia and
gastric carcinoma#IC00011.Melanomastage III YTMA-144-4arrayand
Melanoma stage IV YTMA-205-2 array were a kind gift of Dr. Dave S.
Hoon (JohnWayne Cancer Institute, CA). NOX5 immunohistochemical
(IHC) positive/negative control slides were prepared from a formalin-
fixed, paraffin embedded cell pellet control block. Immunohistochemical
stainingwasperformedwith a LeicaBiosystems’Bond-Max autostainer,
beginning with heat-induced epitope retrieval in citrate buffer. The
Intense R Detection Kit (#DS9263, Leica Biosystems) was used in
addition to a normal horse serum block (Vector Labs) and biotinylated
horse anti-mouse IgG (Vector Labs). NOX5 was used at 1:1000 for
30min. Negative control slides were exposed to a normal mouse IgG2a
isotype reagent (#550339, BD Bioscience) in place of primary antibody.
NOX5 expression was assessed in a comprehensive library of
formalin-fixed, paraffin-embedded tissue samples (TMAs) of 2091
cases (that were found to be adequate for scoring) out of a total of
2414 tumors of various epithelial origins (colon, prostate, breast, small
intestine, stomach, ovary), melanomas, as well as various inflammatory
diseases and normal control tissues. Staining intensities were assessed
by two pathologists as, 0 = negative/no or blush staining, 1+ =weak, 2
+ =moderate, and 3+ = strong. The percentage of stained tumor/lesion
cells was estimated for each case where, 0 = 0% to < 10% were
considered negative, 1 = 10-24%, 2 = 25-49%, 3 = ≥50% of positive
cells. Cases with moderate to strong cytoplasmic reactivity of the
antibody on ≥10% of cells were considered high expressors.
2.4 | RNA analysis: extraction, cDNA synthesis,
and quantitative real-time PCR assay
Total RNA was isolated from cells with the RNeasy Mini Kit (#74104,
Qiagen) according to the manufacturer's protocol. RNA was treated
with DNase (#79254, Qiagen) according to the manufacturer's
specifications (Applied Biosystems, Austin, TX). RNA concentrations
and purity were measured on the NanoDrop ND-1000 apparatus
(Thermo Fisher Scientific). First-strand cDNA was synthesized with a
high-capacity RNA-to-cDNA™ kit (#4387406, Applied Biosystems)
according to the manufacturer's guidelines. Primers were generated
that were specific to each transcript,42 for NOX1, sense 5′-
TGGTCATGCAGCATTAAACTTT-3′ and antisense 5′-AAAACT-
CATTGTCCCACATTGG-3′ (product size: 98 bp); NOX2, sense 5′-
GAGTCTCAGGCCAATCACTTTG-3′ and antisense 5′-
AGTTGGGCCGTCCATACAAAGT-3′ (product size: 94 bp); NOX3,
sense 5′-TTCTTCTGTGGACCTAAAGCTC-3′ and antisense 5′-AA-
TAGAAATGAACACCTCTGGG-3′ (product size: 91 bp); NOX4, sense
5′-TGCATAACAAGTTTTGGCAAGA-3′ and antisense 5′-ATCC-
CATCTGTTTGACTGAGGT-3′ (product size: 76 bp); NOX5, sense
5′-AAGACTCCATCACGGGGCTGCA-3′ and antisense 5′-CCCTTC
AGCACCTTGGCCAGA-3′ (product size: 144 bp); DUOX1 and 2,
sense 5′-CAGTTTGAGTGGCTGGCTGACA-3′ and antisense
5′-GAGGTCGAACTTCTCAGCCAGC-3′ (product size: 108 bp).
NOX5 may exist either as the long NOX5-L or short NOX5-S
isoform. The sequence of NOX5-S is the same as the sequence at
the 3′ end of NOX5-L. The primers (5′-GGAGGATGC-
CAGGTGGCTCCGGT-3′ and antisense 5′-AGCCCCACTACCACG-
TAGCCC-3′) covering a region of NOX5-L, but not NOX5-S, were
used to determine which NOX5 isoform was present in UACC-257
and SK-MEL-5 melanoma cell lines.42 The primers are also common
to NOX5 isoforms α, β, γ, and δ. To further identify the long form
variant of NOX5 present, primers designed for α and γ variants,
sense 5′-GGCCCTGAAGGCTGTAGAGGCA-3′ and antisense
5′-GCGCAGCTCATCCGGGTCAATG-3′ (product size: 326 and
451 bp, respectively); and for β and δ variants, sense 5′- CAGGACGG-
TACTCCGCTGACACCTT-3′ and antisense 5′-GCGCAGCT-
CATCCGGGTCAATG-3′ (product size: 577 and 661 bp, respectively)
were generated.43 All PCR products were electrophoresed on 2%
agarose gels.
For quantitative real-time PCR, total RNAwas extracted from cells
using the RNeasy Mini Kit (#74104, Qiagen) following the manufac-
turer's instructions. Two microgram of total RNA was used for cDNA
synthesis using SuperScript II reverse transcriptase (#100004925,
Invitrogen) and random primers (#48190-011, Invitrogen) in a 20 µL
reaction system. The cycling conditions were as follows: 25°C for
5min, 42°C for 50min, 75°C for 5min. After reaction, the products
were diluted with diethyl pyrocarbonate/H2O to 100 µL for the real-
time PCR. Real-time PCRwas performed on 384-well plates in a 20-µL
reaction system containing 2 µL of diluted cDNA, 1 µL of appropriate
primer (Applied Biosystems TaqMan gene expression assay primers
from Thermo Fisher Scientific; Human β-Actin assay primer
Hs99999903_m1; NOX5 assay primer Hs00225846_m1; Human
HIF-1α assay primer Hs00153153_m1; Human CDKN1B
[p27Kip1] assay primer Hs00153277_m1; and Human SKP2 assay
primer Hs01021864_m1), 7 µL of H2O, and 10 µL of TaqMan 2 × gene
expression master mix reagent (#4304437). The PCR was carried out
using the default cycling conditions, and fluorescence was detected
with the ABI 7900HT sequence detection system (Applied Biosystems,
Foster City, CA). Triplicate determinations were performed for each
sample that was used for the real-time PCR; the mean value was
calculated, and the data in the final figures represents three
independent experiments. Relative gene expression was calculated
as the ratio of the target gene to the internal reference gene (β-Actin)
multiplied by 106 based on the Ct values.
2.5 | Intracellular ROS detection by confocal
microscopy
For detection of intracellular ROS by confocal microscopy, cells were
seeded in 6-well plates at a density of 1 × 106 cells per well in growth
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medium overnight. The next day the cells were washed twice with
phosphate-buffered saline (PBS, pH 7.4), and 10 µmol/L H2-DCFDA in
PBSwas applied to live cells for 15min at 37°C in the dark on the stage
of a confocal microscope. H2-DCFDA-loaded cells were rinsed twice in
PBS, and then either stimulated with 1 µmol/L ionomycin or exposed
to medium for 5min at 37°C in the dark. Confocal microscopy was
performed using an Olympus Fluoview scanning unit equipped with an
argon-krypton laser at 488 nm mounted on an Olympus reflected
fluorescence microscope (Olympus, Nagano, Japan). During scanning
of H2-DCFDA-loaded cells, we observed that prolonged (more than
5 s) irradiation with the xenon lamp or slow scanning with the 488-nm
laser line caused probe oxidation and an artifactual increase in
fluorescence. To avoid this artifact, the cells were initially brought into
focus using standard epifluorescence (xenon lamp excitation). Then,
the epifluorescence was switched off and the specimen was moved
beyond the previously illuminated area. A single scan at one focal plane
using minimum laser intensity (10%) was obtained, and the image was
saved for subsequent measurement of fluorescence intensity with the
Olympus proprietary Fluoview software.
2.6 | Extracellular H2O2 measurement using Amplex
Red®
The Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit (#A22188,
Invitrogen) was used to detect the extracellular H2O2 released by live
cells. Briefly, log-phase UACC-257 cells stably overexpressing NOX5
(Clone 3) were either not treated or treated with 200 nmol/L of
diphenyleneiodonium (DPI) for 2 h. The cells were then washed twice
with 1 × PBS, trypsinized, and dispersed thoroughly to produce a
20-µL cell suspension containing 2 × 104 cells in 1 × KRPG (Krebs-
Ringer phosphate glucose) buffer. The cells were mixed with 100 µL of
Amplex Red® reagent containing 50 µmol/L Amplex Red and 0.1
units/mL of horseradish peroxidase (HRP) in KRPG buffer with or
without 1 µmol/L ionomycin or 500 nmol/L phorbol-12-myristate-13-
acetate (PMA), and incubated at 37°C for 30min. The fluorescence of
the oxidized 10-acetyl-3,7-dihydroxyphenoxazine was measured at an
excitation wavelength of 530 nm and an emission wavelength of
590 nm using a SpectraMax Multiplate reader (Molecular Devices,
Sunnyvale, CA). H2O2 was quantified using an H2O2 standard curve
over a 0-2 μmol/L concentration range. Each value in the figures
represents a mean of triplicate samples.
2.7 | Determination of superoxide generation using a
chemiluminescence assay
Superoxide production was assessed with a commercially available
superoxide anion assay kit (# CS1000-1KT, Sigma-Aldrich) utilizing the
manufacturer's instructions. Thekit is basedon theoxidationof luminol by
superoxide anion resulting in the formation of chemiluminescent light. A
specific, non-toxic enhancer amplifies the chemiluminescent signal.
Briefly, 1 × 106 cells cultured in growth medium were washed and
resuspended in 100μL of assay medium in 96-well plates. To this, assay
buffer containing the reagents for luminol oxidation and the enhancer
were added to the samples in a final volume of 200μL. The sampleswere
mixed and placed immediately into a luminometer, and the chemilumi-
nescencewasmeasured every 30 s for 20min. Assayswere performed in
triplicate. For treatment with DPI (200 nmol/L), cells were pretreated for
2 h in culture medium prior to the assay. To evaluate the effect of PMA
and BAPTA on NOX5-mediated ROS production, 100 μL assay buffer
containing the reagents for luminol oxidation and the enhancer was
prepared to contain either PMA (1μL of a 40μmol/L PMA stock solution)
or BAPTA (1μL of a 2mmol/L BAPTA stock solution) or DMSO control
(1μL). This was then added to 100 μL of assaymedium containing cells to
yielda final concentrationof200 nmol/LPMAand10 μmol/LofBAPTAin
a total volume of 200 μL in 96-well plates. The samples were mixed and
placed immediately into a luminometer, and the chemiluminescence was
measured every 30 s for 20min at 37°C. The specificity of the superoxide
assay was assessed by treatment with superoxide dismutase (SOD)
provided in the kit. Under similar assay conditions, cells that stably
overexpress NOX5 generated superoxide as measured by luminescence
intensities in the range of >107 arbitrary units (see Supplementary
FigureS2). Tomaintain luminescence intensitieswithin comparablevalues
to the UACC-257 parental cells, vector, and NOX5 stable knockdown
cells, only 100 000 cells/sample of UACC-257-NOX5 stably over-
expressing cells were used (for Figure 3C, lower panel), and the assay
was carried out in the absence of an enhancer.
2.8 | Preparation of nuclear extracts and whole cell
lysates
Nuclear extractswere prepared according to the instructions of the nuclear
and cytoplasmic extraction kit (# 78833, Thermo Fisher Scientific). Briefly,
cells were re-suspended in 10 vol of CER I solution containing protease
inhibitors, afterwhichtheywere incubated inCERII solutionon icefor1min
and homogenized. Nuclei were recovered by centrifugation at 14000 rpm
for 5min, and the supernatant was kept as the cytoplasmic extract. The
nuclearpelletwas suspended inNERsolutioncontainingprotease inhibitors
and kept on ice for 40min. The insoluble pellet was removed by
centrifugation at 14000 rpm for 10min. The supernatant was used as
the nuclear extract. For whole cell lysates, cells were washed with PBS,
harvested and lysed with 1×RIPA lysis buffer (#20-188, Millipore,
Temecula, CA) with the addition of a phosphatase inhibitor tablet (#04-
906-837001, Roche Applied Science, Indianapolis, IN) and a protease
inhibitor tablet (Roche, #11-836-153001). Protein concentration was
estimatedusing thePierce™BCAProteinAssayKit (#23227,ThermoFisher
Scientific), and bovine serum albumin (BSA) was used as the standard.
2.9 | Western analysis
The nuclear extracts and whole cell lysates were mixed with an equal
volume of 2 × SDS protein gel loading buffer (#351-082-661, Quality
Biological), and 40 µg of each was loaded onto a 4-20% Tris glycine gel
(# EC6028, Invitrogen). For detection of NOX5 expression, the
extracts and lysates that were mixed with an equal volume of 2 × SDS
loading buffer were not heated prior to loading onto gels. Subsequent
to gel separation, the proteins were electrophoretically transferred
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onto nitrocellulose membranes using I Blot gel transfer stacks (#IB
3010-01, Invitrogen). Themembraneswere blocked in 1 × TBST buffer
with 5% nonfat milk for 1 h at room temperature followed by
incubation with the primary antibody overnight in TBST buffer.
Membranes were washed three times in 1 × TBST buffer and
incubated with horseradish peroxidase-conjugated secondary anti-
body for 1 h at room temperature with shaking. Subsequent to washes
with TBST buffer, the antigen-antibody complex was visualized using
the SuperSignal West Pico Luminol/Enhancer Solution (#1856136,
Thermo Fisher Scientific).
Densitometric analyses of everyWesternanalysis in themanuscript
was performed using the Image Studio™ Software (LI-COR). For whole
cell lysates, protein expression densitometric analysis of each sample
was normalized to that of β-Actin. For samples involving nuclear and
cytoplasmic preparations, densitometric analysiswasnormalized to that
of β-Actin for cytoplasmic proteins and to that of Lamin A/C for nuclear
proteins respectively. For p-Akt (Ser473) and p-GSK3β (Ser9), normal-
izations were done to their respective total Akt and GSK3β proteins.
2.10 | Cell growth assay
Cell lines were plated in logarithmic-phase of growth in tissue culture
dishes and counted daily for 7 days using a cell counter (Cellometer
Auto T4, Nexcelom Bioscience, Lawrence, MA). For experiments
comparing growth of UACC-257-NOX5 overexpressing cells to the
parental cells and vector controls, 10 000 cells were seeded, and for
experiments comparing the growth of the UACC257-shNOX5 cells
relative to the parental cells and vector controls, 40 000 cells were
seeded. Experiments were repeated at least three times with similar
results. For transient knockdown of NOX5 andHIF-1α inWM852 cells
as well as transient knockdown of HIF-1α in UACC-257 cells that
stably overexpress NOX5 (Clone 3), log-phase cells were trypsinized,
and 10 000 cells were transfected with 5 nM of either scrambled
siRNA or gene specific siRNAs, and growth was evaluated by cell
counts after 6 days. All transfections were carried out in triplicates, and
the experiment was repeated in triplicates with similar results. To
evaluate the effect of antioxidants and NADPH oxidase inhibitor on
the growth of UACC-257 cells that stably overexpress NOX5, log-
phase cells (50 000 cells/sample) of UACC-257 parental, vector and
NOX5 overexpressor lines were plated in triplicate. The following day,
the NOX5-overexpressing cells were either untreated or treated with
catalase (500, 1000, and 2000U/mL), NAC (2 and 5mmol/L) or DPI
(100 and 250 nmol/L) for 48 h followed by cell counts. Experiments
were repeated at least three times with similar results.
2.11 | Flow cytometry analysis of 5-bromo-2′-
deoxyuridine (BrdU) incorporation
BrdU incorporation into DNA was detected using an FITC BrdU Flow
Kit (#559619, BD Biosciences, San Jose, CA). UACC-257 cells were
serum starved for 24 h and then cultured in serum-containing media
for 24 h. Cells were pulse-labeled with 10 µmol/L BrdU during the last
30min of incubation in serum-containingmedia. The labeled cells were
collected by trypsinization, centrifuged, and fixed in BD Cytofix/
Cytoperm Buffer. Cells were then permeabilized with BD Cytoperm
Permeabilization Buffer Plus, and fixed again with BD Cytofix/
Cytoperm Buffer. BrdU epitopes were exposed by re-suspending
the tumor cells in DNase (30 μg DNase/106 cells) at 37°C for 1 h. BrdU
was stained with a fluorochrome-conjugated anti-BrdU antibody (1:50
dilution, room temperature for 20min). Total DNA was stained with
20 μL of a 7-aminoactinomycin D (7-AAD) solution (provided with the
Kit) using a 5min incubation. Tumor cells were then resuspended in
1mL PBS. Stained cells were subsequently analyzed using a FACS
Calibur Flow Cytometer (Becton Dickinson, San Jose, CA) equipped
with a 488-nm laser capable of detecting both 7-AAD and FITC.
2.12 | H2AX ELISA assay
For the γ-H2AX immunoassay,44 96-well Pierce white opaque plates
were coated with anti-phospho-Histone H2AX (S139) mouse mono-
clonal antibody (Millipore, # 05-636) diluted to a concentration at
4 μg/mL in 0.1MpH9.6 carbonate buffer (SigmaAldrich), 100 μL/well,
for 2 h at 37°C. Plates were then blocked with 250 μL/well of
Superblock (Pierce) for 1 h at 37°C. 75 μL of either a γ-H2AX synthetic
peptide standard or whole cell extract (UACC-257 parental, vector,
and NOX5 over expressor) was then added to each well and incubated
for 18 ± 2 h at 4°C. Plates were then incubated with 100 μL/well of
2 μg/mL histone H2AX rabbit polyclonal antibody (Abcam, # ab11175)
diluted in 2% BSA/PBS, supplemented with 1 μL/mL mouse serum for
2 h at 24°C. A total of 100 μL/well HRP-conjugated affinity-purified
goat anti-rabbit antibody (KPL, Inc.) was added at a final concentration
of 1 μg/mL diluted in 2%BSA/PBS supplementedwith 1 μL/mLmouse
serum and incubated for 1 h at 24°C. Finally, 100 μL/well of freshly
prepared SuperSignal ELISA Pico Chemiluminescent Substrate (Pierce)
was added to the plate and immediately read on a Tecan InfiniteM200
Pro plate reader. The RLU (relative light unit) values were exported as
an Excel file from the plate reader and pasted into a pre-set γ-H2AX
analysis template. This template automatically generated the γ-H2AX
standard curve. The average γ-H2AX level for each cell extract was
then determined using the standard curve.
2.13 | Statistical analysis
Results are expressed as the mean ± S.D. from at least triplicate
experiments. Statistical differences between mean values of control
and treated samples were assessed using Student's t test; P < 0.05 was
considered statistically significant. Significance levels were designated
as **, P < 0.01 and ***, P < 0.001 throughout.
3 | RESULTS
3.1 | Human melanomas and melanoma cell lines as
well as epithelial malignancies express NOX5
Recently, our laboratory reported substantial expression of NOX5 in
several human cancers with weak expression in non-malignant
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tissues.22 Additionally, an initial screening of human tumor cell lines,
including the NCI-60 cancer cell line panel, as well as an evaluation of
tumor and adjacent normal tissues from surgical resections, also
demonstrated NOX5 expression in breast, prostate, and melanoma
cancer cell lines, as well as in human melanomas that had been
removed at surgery.45 To broaden the scope of our initial findings and
substantiate the relevance of NOX5 expression in various tumors, here
we performed a comprehensive analysis of the frequency of NOX5
expression over a wide range of tumor microarrays. As observed in
Figure 1, with representative images of NOX5 expression in various
tumors, significant expression of NOX5 was observed in melanoma
and cancers of the prostate and breast. Tables 1 and S1 demonstrate
expression of NOX5 in 680/750 melanomas (91%), 132/147 colon
cancers (90%), 219/230 breast carcinomas (95%), 96/161 ovarian
carcinomas (60%), and 152/175 prostate cancers (87%). Normal
human breast and prostate tissues exhibited NOX5 positive staining;
however, both staining intensity and the percentage of positive cells
was lower than in the corresponding tumors. Positive but weak NOX5
staining was observed for 60/85 small intestinal carcinomas (70%), 9/
23 stomach carcinomas (39%), and 46/150 lung carcinomas (31%).
Significant expression of NOX5 observed in malignant melanomas
prompted us to evaluate the relative expression of NOX5 across a
panel of humanmelanoma cell lines. Figure 2A shows the expression of
NOX5 mRNA across the 22 human melanoma cell lines screened. A
wide range of expression was observed across the cell line panel with
low, intermediate, and high level NOX5 mRNA expressors. RT-PCR
was performed in the moderate to high NOX5 expressing SK-MEL-5
and UACC-257 cells with specific primers that detect the seven
homologs of the NADPH oxidases. A PCR product corresponding to
the expected NOX5 sequence (144 bp) was detected in both of these
melanoma cell lines (Supplementary Figure S1).42 Expression of other
NOX family members was minimal or undetectable. To further
delineate the NOX5 variant present in these melanoma cell lines,
primers were designed that would generate PCR products of 326 bp
for NOX5α, 577 bp for NOX5β, 451 bp for NOX5γ, and 661 bp for
NOX5δ.43 RT-PCR revealed that the human melanoma cells express
the long form functional variants of NOX5 (NOX5-L); UACC-257 cells
expresses NOX5α and NOX5γ, and the SK-MEL-5 line expresses all
four (α, β, γ, and δ) NOX5 variants (Supplementary Figure S1).
To further investigate the role of NOX5 in human melanoma,
subsequent studies were carried out in UACC-257 cells that
endogenously have moderately high NOX5 expression. Additionally,
modulation of NOX5 levels in these cells was achieved by generating
stable NOX5 overexpressing (Figure 2B) and NOX5 knockdown
(Figure 2C) UACC-257 clones. To generate stable NOX5-overexpres-
sors, parental UACC-257 cells were transfected with either the vector
control pcDNA 3.1 or the pcDNA-HA-NOX5β plasmid. Several stable
transfectant clones that overexpress HA-tagged-NOX5 as well as the
vector alone were generated and screened. Of these, vector clones
(UACC257-Vector Clones 1 and 2) and stable NOX5-overexpressors
(UACC257-NOX5- Clones 1, 2, and 3) were evaluated for NOX5mRNA
expression by quantitative real-time PCR andNOX5 protein expression
by Western analysis (Figure 2B, left and right panel, respectively).
Subsequent functional studieswere carried out using vector clone1 and
NOX5-overexpressor clone 3. To generate stable NOX5 knockdown
cells, parental UACC-257 cellswere transfectedwith either a scrambled
shVector or shNOX5 plasmid. Three different shNOX5 plasmid
sequences targeting distinct sequences of NOX5 were used. After
selection and screening (detailed in section 2), two UACC257-shVector
clones (Clones 1 and 2) and threeUACC257-shNOX5 clones containing
different NOX5 targeting sequences (Clones 1, 2, and 3) were validated
forNOX5expression levels by both real-timePCRandWestern analysis
(Figure 2C, left and right panels, respectively).
3.2 | Endogenous NOX5 and its stable
overexpression in UACC-257 cells has functional
oxidase activity that is FAD- and Ca2+-dependent
and inducible by PMA and ionomycin
Toassess the correlationbetweenendogenousandoverexpressedNOX5
levels and functional NOX activity, production of both intracellular and
extracellular ROS was determined. Intracellular ROS production was
visualized by confocal microscopy using the redox-sensitive dye
H2-DCFDA. As observed in Figure 3A (upper panel), increased levels
of green fluorescence (DCF) were observed in UACC257-NOX5 over-
expressing cells compared to the parental or vector-transfected UACC-
257 cells, indicative of increased intracellular ROS production. Addition-
ally, exposure to the calcium ionophore ionomycin significantly enhanced
theDCF fluorescence in theNOX5-overexpressing cells by about2.5-fold
compared to both the parental and vector controls (Figure 3A, lower
panel). A similar increase in intracellular ROS levels that was further
enhanced by ionomycin was observed in the UACC-NOX5 overexpress-
ing cells by flow cytometry (data not shown). These results are in concert
with previous studies that havedemonstrated the enhancement ofNOX5
activity by calcium ionophore, consistent with its EF-hand Ca2+-binding
domains.35,36,46 Extracellular H2O2 production was detected using the
Amplex Red reagent in conjunction with HRP. As shown in Figure 3B,
NOX5 can be activated both by the protein kinase C enhancing phorbol
ester PMA,47,48 and by the Ca2+ ionophore ionomycin to generate
extracellularH2O2 (P < 0.05).
47–49Furthermore,NOX5activity is inhibited
by nanomolar concentrations of the flavoprotein inhibitor diphenyle-
neiodonium (DPI; 200 nmol/Lwhichproduces verymodest effects on the
electron transport chain)50,51 as evidenced by a significant inhibition of
PMA- and ionomycin-mediated H2O2 production (Figure 3B).
We next determined extracellular superoxide production by the
luminol chemiluminescence assay and validated that the measured
ROS isNOX5-mediated by using siRNA to specifically downregulate all
isoforms ofNOX5. In Figure 3C, parental UACC-257 cells (upper panel)
were transiently transfected with either a non-specific scrambled
siRNAorwith three differentNOX5 siRNAprimers (primers 1, 2, and 3)
and evaluated for superoxide production after 3 days. Figure 3C (upper
panel) shows that extracellular superoxide production in UACC-257
cells transfected with scrambled siRNAwasmodestly enhanced by the
phorbol ester PMA. However, cells transfected with three different
NOX5 siRNA primers showed a significant decrease in superoxide
production and failed to increase superoxide production when treated
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with PMA (Figure 3C, upper panel). Likewise, when the stable
UACC257-NOX5 overexpressing clone 3 was transiently transfected
with either a scrambled siRNA or NOX5 siRNA (Figure 3C, lower
panel), a modest decrease in superoxide production was observed in
the uninduced condition, whereas, NOX5 siRNA transfection signifi-
cantly inhibited PMA-induced superoxide production. Pretreatment of
both the scrambled transfected UACC-257 and UACC257-NOX5
overexpressing cells with 200 nmol/LDPI for 2 h significantly inhibited
FIGURE 1 Patterns of expression of NOX5 in human multi-tumor microarrays. (A) Representative images for NOX5 positivity to define the
criteria for 0 (negative), 1+ (weak), 2+(moderate), and 3+ (high positive) scoring of NOX5 staining intensity. All represented images are melanoma
cases, ×100 magnification; hematoxylin counterstained. Inset, Strong predominantly cytoplasmic and focal membranous expression of NOX5 in a
lymph node metastatic melanoma (blue arrow). Image, ×350 magnification; hematoxylin counterstained. (B) NOX5 expression in malignant
melanoma (upper panel), prostate adenocarcinoma (middle panel), and invasive ductal carcinoma of the breast (lower panel) relative to their
corresponding normal tissue. IstoypeIgG staining controls are also represented. All images, ×200 magnification; hematoxylin counterstained
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TABLE 1 Immunohistochemical analysis of NOX5 expression in melanoma, prostate and breast tumors, and normal tissues
Organ
Tumor type/
Pathologic
diagnosis No. [+] (%) No. [−] (%)
Low expressors
(weak); No. (%)
High expressors
(Moderate + Strong);
No. (%)
Staining pattern
C = Cytoplasmic,
M =Membranous
All Melanoma 680/750 (91%) 70/750 (9%) 311/680 (46%) 369 (54%) C, occasional M
Cell line Melanoma 13/13 (100%) 0/13 (0%) 4/13 (31%) 9 (69%) C
Skin Normal 0/3 (0%) 3/3 (100%) 0/3 (0%) 0 (0%)
Regional
skin
Melanoma 10/10 (100%) 0/10 (0%) 5 (50%) 5 (50%) C
Distant skin Melanoma 79/85 (93%) 6 (7%) 35 (44%) 44 (55%) C
Lymph node Melanoma 251/272 (92%) 21 (8%) 112 (45%) 139 (55%) C
Sentinel
lymph
node
Melanoma 11/12 (92%) 1 (8%) 4 (36%) 7 (64%) C
Soft tissue Melanoma 9/12 (75%) 3 (25%) 3 (33%) 6 (67%) C
Muscle Melanoma 16/19 (84%) 3 (16%) 9 (56%) 7 (44%) C
Bone Melanoma 11/11 (100%) 0 (0%) 7 (64%) 4 (36%) C
Brain Melanoma 16/19 (84%) 3 (16%) 3 (18%) 13 (82%) C
Lung Melanoma 71/78 (90%) 7 (10%) 32 (45%) 39 (55%) C
Bowel Melanoma 87/95 (92%) 8 (8%) 50 (57%) 37 (43%) C
Stomach Melanoma 10/12 (83%) 2 (17%) 8 (80%) 2 (20%) C
Liver Melanoma 22/24 (92%) 2 (8%) 8 (36%) 14 (64%) C
Spleen Melanoma 14/16 (88%) 2 (12%) 7 (50%) 7 (50%) C
Pancreas Melanoma 18/20 (90%) 2 (10%) 10 (55%) 8 (44%) C
Gallbladder Melanoma 2/2 (100%) 0 (0%) 1 (50%) 1 (50%) C
Adrenal
gland
Melanoma 25/32 (78%) 7 (22%) 8 (32%) 17 (68%) C
Kidney Melanoma 9/11 (82%) 2 (18%) 1 (11%) 8 (89%) C
Ovary Melanoma 6/6 (100%) 0 (0%) 3 (50%) 3 (50%) C
Peritoneum Melanoma 13/14 (93%) 1 (7%) 5 (38%) 8 (62%) C
Lymph node Normal 7/24 (29%) 17 (71%) 4 (57%) 3 (43%) C
Sentinel
lymph
node
Normal 2/6 (33%) 4 (67%) 2 (100%) 0 (0%) C
Muscle Normal 0/3 (0%) 3 (100%) 0 (0%) 0 (0%)
Bone Normal 0/2 (0%) 2 (100%) 0 (0%) 0 (0%)
Brain Normal 1/3 (33%) 2 (67%) 1 (100%) 0 (0%) C
Lung Normal 0/3 (0%) 3 (100%) 0 (0%) 0 (0%)
Bowel Normal 2/2 (100%) 0 (0%) 0 (0%) 2 (100%) C
Liver Normal 7/8 (88%) 1 (12%) 1 (14%) 6 (86%) C
Spleen Normal 0/4 (0%) 4 (100%) 0 (0%) 0 (0%)
Pancreas Normal 3/3 (100%) 0 (0%) 0 (0%) 3 (100%) C
Gallbladder Normal 2/4 (50%) 2 (50%) 1 (50%) 1 (50%) C
Adrenal Normal 3/3 (100%) 0 (0%) 0 (0%) 3 (100%) C
Kidney Normal 0/1 (0%) 1 (100%) 0 (0%) 0 (0%)
Ovary Normal 0/2 (0%) 2 (100%) 0 (0%) 0 (0%)
Organ: Prostate
Tumor type/
Pathologic
diagnosis Subtype No. [+] (%) No. [−] (%)
Low expressors
(weak); No. (%)
High expressors
(Moderate + Strong);
No. (%)
Staining Pattern
C = Cytoplasmic,
M =Membranous
Carcinoma (All) 152/175 (87%) 23/175 (13%) 124 (82%) 28 (18%) C
(Continues)
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superoxide production. Addition of the intracellular calcium chelator
BAPTA-AM (10 µmol/L) or superoxide dismutase (SOD) at the time of
the assay also essentially abolished superoxide production, indicative
of functional NOX5-mediated superoxide formation in UACC-257
cells. Accordingly, Figure 3D shows the stable NOX5 knockdown
clones of UACC-257 that have a significant decrease in superoxide
production compared to the vector control and that fail to increase
superoxide production when treatedwith PMA, confirming the ROS to
be NOX5-mediated.
3.3 | NOX5-derived ROS regulates normoxic HIF-1α
and p27Kip1 expression in tumor cell lines of varying
histological origins
Because ROS have previously been shown to be part of the signaling
cascades regulating HIF-1α under non-hypoxic conditions,52 we investi-
gated whether NOX5-mediated ROS can regulate HIF-1α in UACC-257
cells. As shown in Figure 4A, under normoxic conditions, increased levels of
HIF-1αproteinwereobserved inNOX5overexpressingclones.Conversely,
decreased HIF-1α protein levels were observed in NOX5 knockdown
clones (shNOX5). Enhanced normoxic HIF-1α levels were inversely
correlated with the levels of the cell cycle regulatory protein p27kip1
(Figures 4A and S2A). To validate our observation that NOX5 over-
expression was associated with increased normoxic HIF-1α and decreased
p27kip1 levels, the effect of NOX5 knockdown was next evaluated
(Figures 4B and 4C, and Supplementary Figures S2B and S2C). To this end,
NOX5 was transiently depleted by siRNA in the NOX5-overexpressing
clone 3 (Figures 4B and S2B) and in parental UACC-257 cells
(Figures 4C and S2C) with different NOX5-specific siRNAs (primers 1-3).
Compared with untransfected cells or cells transfected with scrambled
control siRNA, HIF-1α protein levels were markedly reduced in NOX5-
depletedcells (Figures4Band4C,andSupplementaryFiguresS2BandS2C).
TABLE 1 (Continued)
Organ: Prostate
Tumor type/
Pathologic
diagnosis Subtype No. [+] (%) No. [−] (%)
Low expressors
(weak); No. (%)
High expressors
(Moderate + Strong);
No. (%)
Staining Pattern
C = Cytoplasmic,
M =Membranous
Adenocarcinoma 148/171 (87%) 23/171 (13%) 122 (82%) 26 (18%) C/stromal
Transitional cell
carcinoma
4/4 (100%) 0/4 (100%) 2 (50%) 2 (50%) C/luminal secretion/
stromal
Normal (All) 17/17 (100%) 0/17 (0%) 15 (88%) 2 (12%) C/luminal secretion/
stromal
Normal prostate
tissue
6/6 (100%) 0/6 (0%) 4 (67%) 2 (33%) C/luminal secretion/
stromal
Adjacent normal
prostate
tissue
11/11 (100%) 0/11 (0%) 11 (100%) 0 (0%) C/luminal secretion/
stromal
Organ: Breast
Carcinoma (All) 219/230 (95%) 11/230 (5%) 148 (68%) 71 (32%) C
Invasive ductal
carcinoma
211/219 (96%) 8/219 (4%) 140 (66%) 71 (34%) C
Invasive lobular
carcinoma
4/5 (80%) 1/5 (20%) 4 (100%) 0 (0%) C
Tubular
carcinoma
1/1 (100%) 0/1 (0%) 1 (100%) 0 (0%) C
Mucinous
carcinoma
1/1 (100%) 0/1 (0%) 1 (100%) 0 (0%) C
Medullary
carcinoma
2/4 (50%) 2/4 (50%) 2 (100%) 0 (0%) C
Normal (All) 5/6 (83%) 1/6 (17%) 4 (80%) 1 (20%) C
Normal breast
tissue
1/1 (100%) 0/1 (0%) 0 (0%) 1 (100%) C
Cancer adjacent
normal breast
4/5 (80%) 1/5 (20%) 4 (100%) 0 (0%) C
Relative staining intensities observed for NOX5 expression are represented in columns 3 and 4. Staining intensities for NOX5 expression was assessed as
either 0/−, negative/no or blush staining; 1+, weak, 2+, moderate; and 3+, strong. Cases with NOX5 staining intensities (1+, 2+, and 3+) are represented in
column 3 [+], and cases negative for NOX5 staining are represented in column 4 [−]. Additionally, the percentage of stained tumor/lesion cells was also
estimated for each case where, 0, 0% to <10% were considered negative; 1, 10-24%, 2, 25-49%, 3, ≥50% of positive cells. Cases with moderate to strong
cytoplasmic reactivity of the antibody on ≥10% of cells were considered high expressors (column 6). NOX5 staining pattern observed is denoted as either
cytoplasmic (C) or membranous (M).
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A corresponding increase in p27Kip1 expression was observed in cells that
were knocked down for NOX5 expression (Figures 4B and 4C, and
Supplementary Figures S2B and S2C). Consistent with what we observed
for NOX5 overexpression (Figures 4A and S2A), knockdown of NOX5
expression in both parental UACC-257 cells and NOX5-overexpressing
clones reversed the expression levels previously observed: decreasing HIF-
1αand increasingp27Kip1 levels.Here,we identify for the first timethatHIF-
1α and p27Kip1 are key molecules regulated by NOX5-mediated ROS in
UACC-257 cells.
To confirm the functional relevance of NOX5-generated ROS in the
observed increase of normoxic HIF-1α, the NOX5-overexpressing cells
(UACC257-NOX5-Clone3)wereeither treatedwith the reducedthioland
glutathioneprecursorN-Acetyl-L-Cysteine (NAC, 10mmol/L, 24 h), PEG-
Catalase (2000U/mL, 24 h), or PEG-SOD (150U/mL, 24 h). Treatment
with NAC completely prevented NOX5-mediated normoxic HIF-1α
upregulation and p27Kip1 downregulation, suggesting the involvement of
ROS in this response (Figures 4D and S2D). A similar, albeit lesser,
decrease of the normoxicHIF-1α levels and increase in p27Kip1 levelswas
observed with both PEG-Catalase and PEG-SOD treatment
(Figures 4D and S2D). Further investigation revealed that the decrease
in p27Kip1 levels in our stableNOX5overexpressing cells could, in part, be
transcriptionally regulated because of a modest decrease observed in
p27Kip1 mRNA expression following NOX5 overexpression (Figure 4E).
Quantitative real-time PCR confirmed that the accumulation of normoxic
HIF-1α is likely a translational event, rather than due to a transcriptional
regulation, because no accumulation of HIF-1α transcripts was observed
with either NOX5 knockdown or overexpression (Figure 4F).
To evaluate NOX5-mediated effects on normoxic HIF-1α and
p27Kip1 levels further, additional cell types including an inducibleNOX5-
overexpressing UACC-257 system, human WM852 melanoma cells,
human KARPAS 299 lymphoma cells, and human PC-3 prostate cancer
cells were examined. As demonstrated in Supplementary Figure S3,
inducible NOX5-overexpression in UACC-257 cells (Supplementary
Figure S3A), stable NOX5 overexpressing KARPAS 299 cells (Supple-
mentary Figure S3B), and stable NOX5 overexpressing PC-3 cells
(Supplementary Figure S3C) is functional and generates ROS as
measured by luminol chemiluminescence. Functional NOX5 over-
expression in these cells also produces normoxic HIF-1α upregulation
andp27Kip1 downregulation (Supplementary Figure S4A). Conversely, in
theWM852melanoma line, transient knockdownofendogenousNOX5
results in HIF-1α downregulation and p27Kip1 upregulation (Supple-
mentary Figure S4B). Likewise, knockdown of endogenous NOX5 in
parental PC-3 cells leads to p27Kip1 upregulation, and knockdown of
overexpressed NOX5 in PC-3 cells demonstrates HIF-1α down-
regulation (Supplementary Figure S4C). These results strongly suggest
thatHIF-1α stabilization andp27Kip1 levels are regulated, at least in part,
through NOX5-mediated ROS production in human tumor cells.
3.4 | Regulation of nuclear p27Kip1 accumulation by
NOX5-mediated ROS
It has beendocumented that reactive oxygenproductionmaybe linked to
either up- or down-regulation of p27Kip1 expression, depending on cell
context. As shown in Figure 4, UACC-257 cells exhibit decreased p27Kip1
expression when NOX5 expression is increased, and conversely,
increased p27Kip1 levels when NOX5 expression is knocked down. To
further investigate the ROS-mediated regulation of p27Kip1 levels in the
context of NOX5 expression levels, parental UACC-257 cells were
transiently transfectedwith twodifferentNOX5specific siRNAsand their
effects on p27Kip1 localization and phosphorylation were evaluated (see
Figures 5A and S5A). Decreased expression of NOX5 leads to
accumulation of p27Kip1 both in the cytoplasm and the nucleus. Similarly,
transient knockdown of NOX5 expression with siRNAs in UACC257-
NOX5 overexpressing cells also demonstrated an increase of p27Kip1
accumulation both in the cytoplasmaswell as the nucleus (Figures 5B and
S5B).Thephosphorylationofp27Kip1atT157andS10werenot significantly
altered (Figures 5A and S5A). However, alterations in the expression of
known regulators of p27Kip1 were observed followingNOX5 depletion. A
decrease in the phosphorylation of Akt at Ser473 and a decrease in the
phosphorylation of GSK3β at Ser9 with no significant effect on the
expression of the corresponding total proteins were observed upon
knockdown of NOX5 expression (Figures 5A and S5A).
Toexamine thephysiological relationship betweenNOX5,HIF-1α, and
p27Kip1expression status and to determine whether NOX5-mediated
regulation of p27Kip1 expression is HIF-1α dependent, expression levels of
normoxic HIF-1α transcript levels (Supplementary Figure S6A) and protein
levels (Supplementary Figure S6B) across a panel of melanoma cell lines
were evaluated. No significant correlation of expression of HIF-1α levels in
normoxia to endogenous NOX5 levels was observed. However, transient
knockdown of HIF-1α under normoxic conditions in UACC-257 cells that
stably overexpress NOX5 (Supplementary Figure S6C), and in an additional
melanomaWM852cell line (Supplementary FigureS6D), resulted in a slight
increase of p27Kip1 protein levels, suggesting that the regulation of p27Kip1
expression directly by HIF-1α is minimal or modest at best.
Another known mechanism governing p27Kip1 regulation is S-
phase kinase-associated protein 2 (SKP2)-mediated degradation.53 To
assess whether the NOX5-related decrease in p27Kip1 expression is
dependent on or mediated in part by SKP2, the relevance of SKP2
expression to NOX5 and p27Kip1 was evaluated. No significant
correlation between the expression status of SKP2 and NOX5 was
observed in a panel of melanoma cell lines (compare Supplementary
Figures S7A and S7B with Figure 2A). Additionally, comparing UACC-
257 cells that have been genetically altered for NOX5 expression
(stable NOX5 knockdown and stable NOX5 overexpression) did not
show alterations in SKP2 levels (Supplementary Figure S7C), suggest-
ing that NOX5-mediated regulation of p27Kip1 is not SKP2 mediated.
While multiple mechanisms are involved in the regulation of p27Kip1
accumulation, taken together, our results suggest that independent of
HIF-1α and SKP2, NOX5-mediated ROS may regulate p27Kip1and the
Akt/GSK3 signaling pathways.
3.5 | NOX5 expression modulates γH2AX levels and
growth of human UACC-257 melanoma cells
We next evaluated the effect of NOX5 expression on the growth of
UACC-257 cells. As shown in Figure 6A, the UACC257-NOX5
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overexpressing cells exhibit enhanced cell proliferation when com-
pared to either the parental or the vector control (three independent
experiments; P < 0.01). This enhanced cell growth was also supported
by measurement of BrdU incorporation in cells that were starved for
24 h and subsequently released in growth medium for an additional
24 h; NOX5 overexpressors demonstrate an∼1.5- to 2-fold increase in
the number of BrdU positive cells relative to the parental and vector
control cells (Figure 6B). To assess whether the enhanced cell growth
FIGURE 2 NOX5 expression in human melanoma cell lines. Total RNA was extracted from human melanoma cell lines. (A) Quantitative
real-time PCR was carried out to detect endogenous NOX5 expression. Values are expressed relative to β-Actin. (B and C) Stable
overexpression (B) and stable knockdown (C) of NOX5 in UACC-257 cells. UACC-257 cells were transfected with either the vector pcDNA
3.1 or pcDNA3-HA-NOX5β plasmid for stable NOX5 overexpression (B); and with either scrambled shVector or shNOX5 plasmids for stable
NOX5 knockdown (C). Several clones were isolated after G418 selection, of which two clones (Clone 1 and 2) for each of the vector plasmids
(pcDNA 3.1 and scrambled sh) and three clones (Clone 1, 2, and 3) for both the NOX5-overexpressing and NOX5-knockdown were evaluated
for further studies. NOX5 expression was confirmed at the mRNA level (left panel; B and C) and at the protein level (right panel; B and C). To
visualize endogenous expression of NOX5 relative to the NOX5 overexpressors and the decrease of NOX5 expression in the NOX5
knockdowns relative to the endogenous NOX5, additional NOX5 (long exposure [2-5min] and very long exposure [5-10min] of film) panels
are represented. The HA-tag expression confirmed the specificity of the antibody for NOX5 expression. Tables on the right (panels B and C)
represent the densitometric expression of NOX5 protein expression (long exposure) relative to that of β-Actin
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FIGURE 3 Intracellular and extracellular ROS produced by NOX5 in UACC-257 cells is Ca2+- and flavin-dehydrogenase dependent. (A)
upper panel, Ionomycin induces NOX5-mediated ROS production as measured by confocal microscopy. Live staining of log-phase UACC-257
cells was performed as described in section 2. Higher ROS levels were observed in UACC-NOX5-clone 3 cells stimulated with ionomycin
(1 µmol/L) than in parental or vector transfected clones. Representative confocal images of ROS production as detected by DCF fluorescence
(green) and corresponding phase-contrast fields are shown. The lower panel provides the quantitation of fluorescent intensities for three
separate experiments. (B) Extracellular ROS production by overexpression of NOX5 was detected after 30min of treatment with the phorbol
ester PMA (500 nmol/L) or by the Ca2+ ionophore ionomycin (1 µmol/L) using the Amplex Red assay. H2O2 levels were calculated with a
standard curve of 0-2 µmol/L H2O2. The NOX5 enzymatic activity is flavin dehydrogenase-dependent since pretreatment of cells with the
flavoprotein inhibitor DPI (200 nmol/L) for 2 h significantly decreased NOX5-mediated ROS production. (C) Silencing NOX5 by RNAi
significantly inhibited endogenous-, overexpressed-, and PMA-stimulated ROS production. Parental UACC-257 cells (upper panel) and the
NOX5-overexpressing clone 3 (lower panel) were transiently transfected with either control scrambled siRNA or NOX5-specific siRNAs
targeting different domains of human NOX5 (primers 1-3). After 72 h of transfection, cells were trypsinized and analyzed for the effects of
transient silencing of NOX5 expression on ROS production in the parental and NOX5-overexpressing cells in the absence and presence of
200 nmol/L PMA (added immediately at the start of the assay) by luminol chemiluminescence assay. To inhibit NOX5 activity, scrambled
siRNA control cells were either pretreated with DPI (200 nmol/L) for 2 h in culture medium or treated with BAPTA (10 µmol/L) at the time of
the assay. SOD was used to confirm superoxide generation. (D) Log-phase UACC-257 cells that have been stably knocked down for NOX5
(UACC-257-shNOX5-clones 1, 2, and 3) and its appropriate vector control cells (UACC257-Vector-Clone 1) were trypsinized and analyzed for
the effects of stable knockdown of NOX5 expression on ROS production by luminol chemiluminescence assay in the absence and presence of
200 nmol/L PMA (added immediately at the start of the assay). Significant inhibition of both endogenous and PMA-stimulated ROS
production in UACC-257 cells with stable knockdown of NOX5 expression (UACC-257-shNOX5-clones 1, 2, and 3) relative to the
appropriate vector control cells (UACC257-Vector-Clone 1) was observed. **, P < 0.01
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FIGURE 4 NOX5 expression levels in human UACC-257 melanoma cells affect normoxic HIF-1α and p27Kip1 expression. (A) Whole cell
lysates from log-phase UACC-257-vector control clones (scrambled-sh and pcDNA3.1), UACC257-shNOX5 clones (1-3), and UACC257-
NOX5-overexpressing clones (2 and 3) were prepared and analyzed by Western blotting. NOX5 overexpression in UACC-257 cells results in
decreased p27Kip1 expression as well as increased normoxic HIF-1α expression. Conversely, decreased normoxic HIF-1α and corresponding
increased p27Kip1 expression was observed in NOX5 knockdown cells. (B and C) Transient knockdown with NOX5-specific siRNA primers
targeting different domains of human NOX5 in the stably overexpressing NOX5 clone (B) and parental UACC-257 cells (C) results in
decreased normoxic HIF-1α and corresponding increased p27Kip1 expression. (D) Increased normoxic HIF-1α and decreased p27Kip1
expression observed in NOX5-overexpressing cells is ROS-dependent. The NOX5-overexpressing UACC257 clone was treated with NAC or
PEG-Catalase or PEG-SOD and examined by Western analysis. Densitometric analysis of western blot analyses (Panels A-D) of the expression
of the various proteins relative to that of β-Actin are represented in Supplementary Figure S3. (E) Total RNA was isolated from log phase
parental UACC-257 cells, UACC-257 cells that were transiently transfected with either scrambled control or two different NOX5-specific
siRNAs, and UACC-257 clones that stably overexpress either NOX5 or the vector. Real-time PCR analysis of p27Kip1 mRNA expression levels
are expressed relative to β-Actin. (F) Total RNA from parental UACC-257 cells and stable NOX5-overexpressing clone 3 cells transiently
transfected with either a scrambled siRNA or NOX5-specific siRNAs, stable vector clones and two additional NOX5 overexpressing clones
were isolated. Real-time PCR analysis of HIF-1α mRNA levels are expressed relative to β-Actin. **, P < 0.01
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observed in the UACC257-NOX5 overexpressing cells was ROS-
mediated, the UACC257-NOX5 overexpressing cells were treated
with either antioxidants (catalase and NAC) or the flavoprotein
inhibitor DPI. Figure 6C shows a dose dependent decrease in cell
growth of UACC257-NOX5 overexpressing cells by catalase, NAC and
DPI; indicative of a ROS-mediated role in their proliferation (two
independent experiments; P < 0.01). To examine the possibility that
NOX5-related ROSmight contribute to enhanced genetic instability of
UACC-257 cells, we evaluated the activation of phosphorylated
γH2AX, a biomarker for DNA damage and repair. As shown in
Figure 6D, we found 30% more phosphorylated γH2AX in the NOX5
overexpressors compared to the parental and vector control cells.
Conversely, stable knockdown of NOX5 expression in UACC-257 cells
(see Figure 6E) and transient knockdown of NOX5 expression in
WM852 cells (see Figures 6F and S8) substantially decreased cell
proliferation (three independent experiments; P < 0.01); suggesting
that NOX5-mediated pro-oxidant tone is necessary for the prolifera-
tion of UACC-257 and WM852 cells.
4 | DISCUSSION
A pro-oxidant environment favoring tumor cell growth has been
supported by several studies showing upregulated expression and/
or activity of ROS generating proteins and their downstream
signaling effectors.2,7,10,54 In this investigation, our TMA analyses
substantiate the observation that NOX5 is significantly overex-
pressed in melanomas and cancers of the prostate and breast (see,
Figure 1, Tables 1 and S1) compared to non-malignant tissues of the
same histological origin. Particularly in the context of human
melanoma, NOX5 positivity in 91% of the cases studied compared
to a lack/minimal NOX5 staining in normal human skin was
significant. As detailed in Table 1, among the 680 out of 750
human melanoma patient samples that stained for NOX5 expression,
≥75% of the cells were positive in 84% of the cases. Additionally, in
83 of these patients, the NOX5 staining was strong (3+).
Surprisingly, under standard tissue culture conditions, themajority
of the human melanoma cell lines we screened have low to minimal
expression of the NOX5 transcript (Figure 2A). This apparent
discrepancy between NOX5 expression levels in human melanoma
patient samples versus tissue cultured cell lines is not an anomaly; our
laboratory and others have documented that expression of some
members of the NOX gene family (particularly NOX1 and DUOX2) is
strongly upregulated under proinflammatory conditions both in vitro
(following cytokine exposure) and in vivo.55 In contrast, a discordance
in the opposite direction between NOX5 expression in clinical
specimens and cultured cell lines was recently reported in prostate
cancer, wherein, prostate cancer cell lines demonstrated higher NOX5
protein expression levels compared to non-malignant prostate cell
lines, while no significant difference was observed in clinical speci-
mens.24 This discordance with our observation of increased NOX5
expression in prostate cancer clinical samples relative to histologically
normal prostate tissue could, in part, be due to differences in the
sample sizes of the tissues examined and/or the immunohistochemical
detection method using different NOX5 antibodies.24 While epige-
netic regulation of NOX5 expression has only recently begun to be
explored, it is one of many possible explanations for the down/up
regulation of NOX5 expression in cultured cell lines, an area of
investigation that remains largely unexplored.
Because pathological evidence suggested a role for NOX5 in
human melanomas, we next assessed whether the intracellular redox
status regulated by NOX5 was critical for the proliferation of
melanoma lines. HIF-1α, a known sensor of cellular oxidant load,
which regulates the expression of a wide variety of proliferative and
angiogenic genes, was significantly upregulated in the context of
NOX5-generated ROS. Under normoxic conditions, HIF-1α expression
was significantly increased in cells that overexpressNOX5; conversely,
HIF-1α levels were decreased in NOX5-deficient cells (Figures 4
and 5A, and Supplementary Figures S2, S4, and S5A) albeit
physiologically not correlated across a panel of melanoma cell lines
(compare Figure 2Awith Supplementary Figures S6A and S6B). Several
mechanisms of ROS-dependent upregulation of HIF-1α protein levels
have been described under both normoxic and hypoxic conditions.56
This regulation of HIF-1α can either be at the level of protein stability
or its synthesis. Transcriptionally, regulation of HIF-1α synthesis has
been attributed to the activation of NF-κB and its binding to the HIF-
1α promoter or to regulation by the activation of MAPK/Akt signaling
pathways.57,58 Translationally, HIF-1α levels are increased by the
altered regulation and inactivation of prolyl hydroxylases, in part
through the oxidation of critical stores of Fe2+; diminished levels of
intracellular reducing equivalents, such as ascorbate, that maintain the
iron redox state could decrease the degradation of HIF-1α protein.59
Under hypoxic conditions prolyl hydroxylation and ubiquitin-mediated
proteasomal degradation of HIF-1α are suppressed, resulting in HIF-
1α accumulation and stabilization by dimerization with HIF-1β.60 As
seen in Figure 4F, transcriptional levels of HIF-1α in UACC-257 cells
remained unaltered irrespective of an increase or a decrease in NOX5
expression, suggesting that HIF-1α regulation by NOX5 may be
primarily translational by one or another oxidant-sensitive effects.
Addition of PEG-catalase and PEG-SOD (to increase intracellular ROS
detoxifying capacity)61 or a ROS scavengerN-Acetyl-L-Cysteine (NAC)
to UACC-257 cells overexpressing NOX5 significantly decreased
NOX5-upregulated HIF-1α expression (Figure 4D), confirming HIF-1α
upregulation to be mediated by NOX5-generated ROS signaling. This
normoxic NOX5-ROS-HIF-1α signaling axis sets up a pro-inflamma-
tory milieu that could serve as a potent angiogenic stimulus, conducive
to enhanced tumor growth and invasion.62
Notably, the expression levels of p27Kip1, a member of the Cip/Kip
family, known to modulate cell cycle progression were also
significantly influenced by NOX5 expression. In cells that stably
overexpress NOX5, p27Kip1 protein levels were decreased; and
conversely, cells with decreased NOX5 expression exhibited increased
p27Kip1 levels (Figures 4, 5, and Supplementary Figures S2, S4, and S5).
Downregulation of p27Kip1 protein levels, in particular nuclear p27Kip1,
is implicated in both disease progression and poor prognosis in a
variety of cancers.63,64 However, the effects of p27Kip1 are regulated
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by concentration, subcellular localization, and phosphorylation sta-
tus.64–66 Post-translationally, p27Kip1 is modified predominantly by
phosphorylation; Thr187 phosphorylation leading to nuclear degrada-
tion, Ser10 phosphorylation stimulating nuclear export and subsequent
degradation, and Tyr74, Tyr88, and/or Tyr89 phosphorylation diminish-
ing its CDK-inhibitory activity. Less common and not well understood
is the phosphorylation of p27Kip1 at Thr157 and Thr198 by Akt, p90-S6
kinases, AMPK, and PIM, that impairs its nuclear import resulting in
cytoplasmic localization.
In UACC-257 cells that stably overexpress NOX5, the observed
decrease in p27Kip1 levels may, in part, be transcriptionally regulated
since a modest decrease in p27Kip1 transcript levels was observed
(Figure 4E). Additionally, in both parental and stable NOX5 over-
expressing cells, knockdown of NOX5 increased both nuclear and
FIGURE 5 Increased nuclear and cytoplasmic p27Kip1 following knockdown of both endogenous and overexpressed NOX5 in UACC-257
cells. To assess the translational regulation of p27Kip1 by NOX5, log-phase parental UACC-257 cells (A) or UACC-NOX5 overexpressing clone
3 (B) were transfected with either scrambled or two different NOX5-specific siRNAs. Nuclear and cytoplasmic extracts were prepared 72 h
after transfection, and the expression levels of various proteins were examined by Western analysis. Blots are representative of HIF-1α,
NOX5, Akt, phospho-Akt (Ser473), GSK3β, phospho-GSK3β (Ser9), p27Kip1, phospho-p27Kip1 (Thr157 and Ser10), Lamin A/C, and β-Actin
expression from three independent experiments. Densitometric analyses of the Western blots from panels A and B for the expression of the
various proteins are represented in Supplementary Figure S5
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FIGURE 6 NOX5 expression alters the growth and DNA damage levels of UACC-257 cells. (A) NOX5 overexpression promotes the growth
of UACC-257 cells. Growth of logarithmic phase UACC-257, vector and NOX5 overexpressing cells was measured by daily cell counts;
10 000 cells were plated in triplicate for each cloned line and the parental cells. The data are expressed as the mean ± SD of three
independent experiments, **, P < 0.01. (B) Cell cycle analysis was performed using flow cytometry following BrdU labeling of UACC-257
parental and each cloned line that were serum-starved and then released in full growth media for 24 h. The percentage of cells in the
different phases of the cell cycle is shown in the table. (C) Effect of antioxidants (NAC and catalase) and the flavoprotein inhibitor
diphenyleneiodonium (DPI) was evaluated on the growth of the NOX5 overexpressing cells as measured by cell counts subsequent to 48 h
treatment. Data represent the mean ± SD of two independent experiments, **, P < 0.01. (D) γH2AX levels in exponentially growing UACC-257
parental and cloned lines were quantified using a γH2AX and H2AX sandwich ELISA immunoassay as described in the Materials and Methods
section. (E) Stable knockdown of NOX5 expression decreases the growth of UACC-257 cells. Growth of logarithmic phase UACC-257, vector,
and NOX5 knockdown cells was measured by daily cell counts; 40 000 cells were plated in triplicate for each cloned line and the parental
cells. The data are expressed as the mean ± SD of three independent experiments, **, P < 0.01. (F) Effect of transient knockdown of NOX5
expression on cell growth was evaluated in an additional melanoma cell line; WM852. Cells transfected with either scrambled siRNA or
NOX5-specific siRNA primers targeting different domains of human NOX5 were evaluated after 6 days for NOX5 RNA expression (left panel)
and for cell growth (right panel) by cell counts. The data are expressed as the mean ± SD of triplicates,**, P < 0.01 and ***, P < 0.001. The
experiment was repeated in triplicates with similar results. Representative images of the effect of NOX5 knockdown on the growth of
WM852 cells and the effect on ROS production are represented in Supplementary Figure S6
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cytoplasmic expression of p27Kip1 (Figures 5A and 5B). No significant
alterations in the phosphorylation status of p27Kip1 at either Ser10 and
Thr157 were noted. Significantly, the observed alterations in p27Kip1
levels were also SKP2 independent (Supplementary Figure S7).
The NOX5-expression dependent, reciprocal expression levels of
p27Kip1 and HIF-1α in UACC-257 cells appears contradictory, as
several groups have shown that during hypoxia the induction of the cell
cycle inhibitors p21Cip1 and p27 Kip1 is dependent on HIF-1α.67
However, the regulation of p27Kip1 by HIF-1α is still an area of debate
within the hypoxia field68 as other studies have shown that p27Kip1 is
regulated independently of HIF-1α, through transcriptional regulation
of its proximal promoter.69 Additionally, studies to characterize the
role of HIF-1α in normoxia report that knockdown of HIF-1α resulted
in significantly increased protein and mRNA of both p21Cip1 and
p27Kip1, induced via, at least in part, p53-independent but SP1-
dependent mechanisms.70 Similar reciprocal levels of expression of
HIF-1α and p27Kip1 have been reported in LNCaP prostate cancer cells
under hypoxia.71 Likewise, UACC-257 cells that stably overexpress
NOX5 exhibit upregulated, normoxic HIF-1α expression; transiently
knocking down the normoxic HIF-1α resulted in increased p27Kip1
protein levels, without significantly affecting cell growth (Supplemen-
tary Figure S6C). A similar increase in p27Kip1 protein expression was
observed in WM852 cells when normoxic HIF-1α expression was
transiently knocked down (Supplementary Figure S6D). While a
reciprocal effect of NOX5-mediated ROS on the expression levels of
p27Kip1 and HIF-1α is clear, evidence of a direct effect of HIF-1α on
p27Kip1 expression is minimal and at best, modest.
While additional studies are needed to understand the precise
mechanisms associated with NOX5-redox-induced regulation of
p27Kip1 expression, another possibility is an alteration in the status
of redox-sensitive thiol-disulfide reactions at the two critical residues
within the cyclin A binding domain of p27Kip1.72 Although the role of
these cysteines in redox regulation of G1 to S phase is speculative, it is
reasonable to suggest that thiol-redox reactions could act as
“sulfhydryl switches” that reversibly modulate cell cycle-regulatory
protein activity.73 This hypothesis is supported by our studies of BrdU
incorporation (increased S-phase fraction) which may underlie the
observed pro-proliferative effects. Redox-dependent downregulation
of p27Kip1 expression in the presence of NOX5 is supported by our
experiments using NAC, PEG-Catalase, and PEG-SOD that reversed
the effects of NOX5 overexpression (Figure 4D).
In support of our findings, lowering oxidative stress by exposing
CH72-T4 carcinoma cells to catalase was shown to arrest cells at the G1
phase of the cell cycle and increase p27Kip1 expression74; addition of cell-
permeable SOD to SPC-A-1 lung adenocarcinoma cells inhibited cell
proliferation through the Akt/p27Kip1 pathway.75 More recently, “non-
canonical” roles of p27Kip1 in the regulation of cell migration have also
been described, in addition to effects on other processes such as cell
differentiationandapoptosis.76Takentogether,wespeculate thatbesides
a cell cycle regulatory role, redox regulation of p27Kip1 status in UACC-
257 melanoma cells could influence other features of melanoma biology,
including cell migration, potentially altering tumor aggressiveness, and
metastasis.
Significantly, in the absence of NOX5 expression, the Akt/GSK3
signaling pathway was inhibited in UACC-257 cells, as observed by their
decreased phosphorylation (Figure 5A). Akt, an important kinase that
promotes G1-S phase cell cycle progression by phosphorylating and
inactivating glycogen synthase kinase 3 (GSK3) at Ser9, is a downstream
componentofsignalingpathways involvingprotein tyrosinephosphatases
(PTPs).77,78 Accordingly, in ROS generating NOX5 cells, PTP activity was
significantly inhibited (data not shown), offering one plausiblemechanism
bywhich NOX5-generated ROS-induced inactivation of PTPs leads to an
active Akt kinase, a known regulator of cell cycle genes that control
anchorage-independent growth of cancer cells.78,79
In addition to the enhanced pro-oxidant tone conferred by NOX5
overexpression, we also observed that UACC-257 cells that overexpress
NOX5 proliferate faster (Figure 6A). Enhanced cell proliferation byNOX5
overexpressing cells is clearly distinguishable from both parental cells and
vector controls after a week in culture. However, within 24 h of release
from serum starvation, a marked increase in BrdU incorporating cells,
reflective of an S-phase population, supports the enhanced growth of
NOX5 overexpressing cells (Figure 6B). Interestingly, these cells were
characterized by an increase in the DNA damage and repair biomarker
γH2AX. In contrast, knocking down endogenousNOX5 expression (using
three different NOX5shRNA plasmids that target different sequences in
NOX5) in UACC-257 cells markedly slows cell growth (Figure 6E),
confirming that NOX5 expression regulates UACC-257 cell proliferation.
Enhanced cell growth in the presence of NOX5 in UACC-257 cells could,
in part, be due to the downstream redox signaling pathways that are
activated due to altered phosphatase function.
Collectively, our results suggest a new molecular paradigm by which
NOX5-mediated ROS-inducible signal-transduction pathway(s) may con-
tribute to the growth ofmelanoma cells and other human tumors,80 in part,
through mechanisms that involve genomic instability and activation of the
Akt/GSK3, p27Kip1, and HIF-1α signaling pathways. Intracellular redox
status maintained by NOX5 is critical for sustaining cell growth and may
contribute to the establishment of a pro-angiogenic milieu that adversely
affects clinical outcome for patients with melanomas.
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